Overall rank by patents
#2,330
of 49,997 tracked assignees
USPTO PatentsView assignee record - 168 granted patents across 53 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).
The verdict
According to USPTO PatentsView, Korea ranks #2,330 of 49,997 tracked US assignees by granted-patent volume, with 168 patents across 53 technology areas.
USPTO PatentsView assignee plate
Corpus R2330 · Foreign Corporation #2,330 · 168 grants
GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-WIDE · INNOV-PAR · CLAIMS-PAR · TYPE-FRNCORP · VEL-DROP · BOOK-FULL
Nearest grant-volume peer: Extreme Networks, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
BorgWarner Ludwigsburg · near
51 score
Chatsworth Products · near
51 score
Korea Research… · this assignee
51 score
Kurita Water… · near
51 score
Tamura · near
51 score
3D Lighting… · lowest
7 score
What this shows Korea's Innovation Score is 50.8/100 (top 12% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Between 2020–2024, Korea Research Institute OF Bioscience AND Biotechnology received 35 grants versus 119 in 2015–2019 (-71% equal-window velocity, below median growth). Across complete PatentsView years, output peaked in 2015 at 29 grants and bottomed in 2022 at 4. Lead class A61K accounts for 54.8% of the portfolio across 53 subclasses. Volume neighbours: Extreme Networks, Inc. (#2,326) and Oerlikon Surface Solutions AG, Pfäffikon (#2,334).
From 2019–2021 to 2022–2024, Korea Research Institute OF Bioscience AND Biotechnology moved from 38 to 14 grants (0.37x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #2,918. See the growth leaderboard.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Extreme Networks, Inc.
168 patents
General Electric Renovables Espana, S.L.
168 patents
Ingersoll-Rand Industrial U.S., Inc.
168 patents
Intellectual Ventures II LLC
168 patents
Magna Exteriors Inc.
168 patents
NLT Technologies, Ltd.
168 patents
Netronome Systems, Inc.
168 patents
Oerlikon Surface Solutions AG, Pfäffikon
168 patents
Korea Research Institute OF Bioscience AND Biotechnology
168 patents
What this shows Korea holds 168 patents at rank #2,330, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #2,330 in granted patent volume.
Other assignees with the most granted patents in Korea's primary technology class.
Two PlainPatent-derived peer sets for Korea, neither rank-band nor same-CPC leaders (those blocks stay above).
Nearest assignees by Innovation Score (51 here).
Nearest assignees by average claims per patent (9.3 here).
Korea's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
51 Top 12% higher than 88% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 29 | 17.3% |
| 2016 | 26 | 15.5% |
| 2017 | 26 | 15.5% |
| 2018 | 21 | 12.5% |
| 2019 | 17 | 10.1% |
| 2020 | 13 | 7.7% |
| 2021 | 8 | 4.8% |
| 2022 | 4 | 2.4% |
| 2023 | 5 | 3.0% |
| 2024 | 5 | 3.0% |
| 2025partial year | 14 | 8.3% |
Top 15 of 53 technology areas
Overall rank by patents
#2,330
of 49,997 tracked assignees
50.8 out of 100
What to do with this data
Korea Research Institute OF Bioscience AND Biotechnology's patent record in context - here's where to go next.
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.